Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone.
about
Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study.Preliminary Evidence of Increased Pain and Elevated Cytokines in Fibromyalgia Patients with Defective Growth Hormone Response to Exercise.GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?Preliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgia.Fibromyalgia: aetiology, diagnosis, symptoms and management.A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgiaAdvances in diagnostic and treatment options in patients with fibromyalgia syndromeDoes muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue?Fibromyalgia and obesity: the hidden link.Fibromyalgia: A Critical and Comprehensive Review.Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia.GH Responsiveness to Combined GH-Releasing Hormone and Arginine Administration in Obese Patients with Fibromyalgia Syndrome.Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus.Chronic spinal and oral morphine-induced neuroendocrine and metabolic changes in noncancer pain patients.[Fibromyalgia].[Fibromyalgia: interfaces to RSI and considerations about work etiology].[Treatment of fibromyalgia syndrome with gamma-hydroxybutyrate : A randomized controlled study].
P2860
Q33308283-580C46A1-706A-4161-B977-EA5CAFB77230Q33844288-83D66633-800E-4F6D-8E75-4C83D396DB7DQ34338003-6C4784EA-3299-4D9D-A410-EFDAE87181FAQ35039967-AA1AA8C1-7ABE-42BA-8795-9CBD6A89436EQ36574495-E178DF14-3A59-404A-8B61-56A269197BDEQ36891092-44B106C5-1C15-4261-B9E6-77FFAD146DBEQ37358110-4BE87782-D877-4DD4-97B5-5FDC9E12063EQ37590990-D81C99D9-AE26-48E6-853D-CEFB3371B3CDQ37863057-B2A3A08D-6EA8-47B8-8797-7B8773F50E96Q38601633-51417A01-AF07-410B-9CB7-6C52A071259BQ40300693-D016B281-FBC6-4789-A918-241A41358DFFQ40989073-D1D09F9A-96C0-4399-9754-F1CE42C95A73Q47211288-4FD185DC-796D-467A-9AE0-31F9206CEB3FQ48407756-F9E59755-EFD1-4EEC-A3AC-80C800BE2C25Q50993412-CBDF6587-B75E-4B25-B44E-44C3E0C0E6A3Q52350293-77A0C0B9-A833-45CF-99C7-3687FD82DD19Q52845548-22D038DC-608B-4FEA-9CC1-F3592F1453E1
P2860
Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Impaired growth hormone secret ...... ypothalamic somatostatin tone.
@en
Impaired growth hormone secret ...... ypothalamic somatostatin tone.
@nl
type
label
Impaired growth hormone secret ...... ypothalamic somatostatin tone.
@en
Impaired growth hormone secret ...... ypothalamic somatostatin tone.
@nl
prefLabel
Impaired growth hormone secret ...... ypothalamic somatostatin tone.
@en
Impaired growth hormone secret ...... ypothalamic somatostatin tone.
@nl
P2093
P2860
P356
P1476
Impaired growth hormone secret ...... ypothalamic somatostatin tone.
@en
P2093
Atul Deodhar
Eduardo S Paiva
Kim D Jones
P2860
P304
P356
10.1002/ART.10209
P577
2002-05-01T00:00:00Z